nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—SLC22A7—Valproic Acid—epilepsy syndrome	0.142	0.292	CbGbCtD
Ganciclovir—SLC22A1—Midazolam—epilepsy syndrome	0.116	0.239	CbGbCtD
Ganciclovir—SLC22A8—Valproic Acid—epilepsy syndrome	0.0865	0.178	CbGbCtD
Ganciclovir—SLC22A6—Acetazolamide—epilepsy syndrome	0.0807	0.166	CbGbCtD
Ganciclovir—SLC22A6—Valproic Acid—epilepsy syndrome	0.0603	0.124	CbGbCtD
Ganciclovir—SLC22A1—Neuronal System—NSF—epilepsy syndrome	0.000172	0.0022	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—SYN1—epilepsy syndrome	0.000172	0.0022	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000171	0.00219	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000171	0.00219	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000171	0.00219	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.00017	0.00217	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.00017	0.00217	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—GAD2—epilepsy syndrome	0.00017	0.00217	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—STXBP1—epilepsy syndrome	0.000167	0.00214	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000166	0.00212	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000165	0.00211	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—SLC1A1—epilepsy syndrome	0.000163	0.00208	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000161	0.00205	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000161	0.00205	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.00016	0.00205	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000157	0.00202	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000157	0.00201	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—ABAT—epilepsy syndrome	0.000155	0.00199	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GABRA5—epilepsy syndrome	0.000155	0.00199	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—CACNA1A—epilepsy syndrome	0.000155	0.00199	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GRIA4—epilepsy syndrome	0.000155	0.00199	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—KCNJ10—epilepsy syndrome	0.000155	0.00199	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—GRIK2—epilepsy syndrome	0.000154	0.00197	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—SLC1A3—epilepsy syndrome	0.000154	0.00197	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000153	0.00196	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000152	0.00195	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000152	0.00195	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000152	0.00195	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—ARHGEF9—epilepsy syndrome	0.000149	0.00191	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—SLC17A7—epilepsy syndrome	0.000149	0.00191	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GABRB3—epilepsy syndrome	0.000149	0.00191	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GABRA1—epilepsy syndrome	0.000149	0.00191	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000149	0.0019	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000149	0.0019	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000149	0.0019	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—GAD1—epilepsy syndrome	0.000147	0.00188	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.000147	0.00188	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000147	0.00188	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000147	0.00188	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000147	0.00188	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000147	0.00188	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000146	0.00187	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GLUL—epilepsy syndrome	0.000146	0.00187	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GRIA2—epilepsy syndrome	0.000143	0.00183	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000143	0.00183	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000142	0.00181	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000142	0.00181	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—GABBR1—epilepsy syndrome	0.00014	0.0018	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000139	0.00178	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000138	0.00177	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—CHRNA7—epilepsy syndrome	0.000138	0.00177	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GRIK1—epilepsy syndrome	0.000138	0.00177	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—SLC1A2—epilepsy syndrome	0.000138	0.00177	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—SLC6A1—epilepsy syndrome	0.000137	0.00175	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—GRIA1—epilepsy syndrome	0.000137	0.00175	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—GRIN2A—epilepsy syndrome	0.000137	0.00175	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000136	0.00175	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000135	0.00173	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000135	0.00173	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GABRB2—epilepsy syndrome	0.000132	0.00169	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.00013	0.00167	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GAD2—epilepsy syndrome	0.00013	0.00167	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—CHRNB2—epilepsy syndrome	0.00013	0.00166	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000129	0.00165	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000129	0.00165	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000128	0.00164	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000125	0.0016	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000124	0.00159	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.000124	0.00158	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000123	0.00158	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000123	0.00158	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000123	0.00158	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000123	0.00158	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—KCNMA1—epilepsy syndrome	0.000123	0.00158	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000122	0.00156	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.00012	0.00154	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	0.00012	0.00154	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—CHRNA4—epilepsy syndrome	0.000118	0.00151	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GRIK2—epilepsy syndrome	0.000118	0.00151	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—KCNJ11—epilepsy syndrome	0.000118	0.00151	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—SLC1A3—epilepsy syndrome	0.000118	0.00151	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000116	0.00149	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000116	0.00149	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000116	0.00148	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000115	0.00148	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000115	0.00148	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000115	0.00148	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000115	0.00147	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GAD1—epilepsy syndrome	0.000113	0.00144	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000113	0.00144	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000113	0.00144	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000111	0.00142	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000111	0.00142	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.00011	0.00141	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.00011	0.00141	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000109	0.0014	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000108	0.00138	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GABBR1—epilepsy syndrome	0.000108	0.00138	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000107	0.00138	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000105	0.00134	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GRIN2A—epilepsy syndrome	0.000105	0.00134	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—SLC6A1—epilepsy syndrome	0.000105	0.00134	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GRIA1—epilepsy syndrome	0.000105	0.00134	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—BCHE—epilepsy syndrome	0.000104	0.00133	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000103	0.00132	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.000103	0.00132	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000103	0.00132	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000103	0.00132	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000103	0.00132	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000103	0.00132	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—DLG4—epilepsy syndrome	0.000101	0.0013	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000101	0.00129	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	0.000101	0.00129	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—CHRNB2—epilepsy syndrome	9.93e-05	0.00127	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—GRIN2B—epilepsy syndrome	9.9e-05	0.00127	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—PLCB1—epilepsy syndrome	9.79e-05	0.00125	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	9.75e-05	0.00125	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	9.75e-05	0.00125	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	9.57e-05	0.00123	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	9.46e-05	0.00121	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CA13—epilepsy syndrome	9.41e-05	0.00121	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	9.35e-05	0.0012	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	9.22e-05	0.00118	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	9.13e-05	0.00117	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—CHRNA4—epilepsy syndrome	9.02e-05	0.00115	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	9e-05	0.00115	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	8.98e-05	0.00115	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	8.76e-05	0.00112	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	8.75e-05	0.00112	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	8.75e-05	0.00112	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	8.69e-05	0.00111	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	8.43e-05	0.00108	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	8.42e-05	0.00108	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	8.35e-05	0.00107	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	8.14e-05	0.00104	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	8.14e-05	0.00104	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	8.02e-05	0.00103	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	8e-05	0.00102	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	8e-05	0.00102	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	8e-05	0.00102	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	8e-05	0.00102	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	7.95e-05	0.00102	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—BCHE—epilepsy syndrome	7.95e-05	0.00102	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	7.84e-05	0.001	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	7.8e-05	0.000999	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—DLG4—epilepsy syndrome	7.76e-05	0.000993	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	7.75e-05	0.000992	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GRIN2B—epilepsy syndrome	7.58e-05	0.000971	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—PLCB1—epilepsy syndrome	7.5e-05	0.00096	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	7.48e-05	0.000957	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	7.44e-05	0.000952	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	7.27e-05	0.00093	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	7.26e-05	0.000929	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—L2HGDH—epilepsy syndrome	7.14e-05	0.000913	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PDXK—epilepsy syndrome	7.14e-05	0.000913	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GLUD1—epilepsy syndrome	7.14e-05	0.000913	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ADK—epilepsy syndrome	7.14e-05	0.000913	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CERS1—epilepsy syndrome	7.14e-05	0.000913	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—FAR1—epilepsy syndrome	7.14e-05	0.000913	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	7.1e-05	0.000909	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	6.99e-05	0.000895	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	6.8e-05	0.000871	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	6.64e-05	0.00085	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	6.59e-05	0.000843	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	6.55e-05	0.000838	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	6.54e-05	0.000837	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—EPM2A—epilepsy syndrome	6.53e-05	0.000835	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NHLRC1—epilepsy syndrome	6.53e-05	0.000835	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GAMT—epilepsy syndrome	6.53e-05	0.000835	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PNPO—epilepsy syndrome	6.53e-05	0.000835	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	6.47e-05	0.000828	CbGpPWpGaD
Ganciclovir—Hypertension—Pregabalin—epilepsy syndrome	6.33e-05	0.000145	CcSEcCtD
Ganciclovir—Vomiting—Diazepam—epilepsy syndrome	6.33e-05	0.000145	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	6.33e-05	0.00081	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	6.33e-05	0.00081	CbGpPWpGaD
Ganciclovir—Anorexia—Valproic Acid—epilepsy syndrome	6.31e-05	0.000144	CcSEcCtD
Ganciclovir—Tremor—Gabapentin—epilepsy syndrome	6.3e-05	0.000144	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	6.29e-05	0.000805	CbGpPWpGaD
Ganciclovir—Rash—Diazepam—epilepsy syndrome	6.28e-05	0.000144	CcSEcCtD
Ganciclovir—Dermatitis—Diazepam—epilepsy syndrome	6.27e-05	0.000143	CcSEcCtD
Ganciclovir—Visual impairment—Topiramate—epilepsy syndrome	6.26e-05	0.000143	CcSEcCtD
Ganciclovir—Myalgia—Pregabalin—epilepsy syndrome	6.24e-05	0.000143	CcSEcCtD
Ganciclovir—Arthralgia—Pregabalin—epilepsy syndrome	6.24e-05	0.000143	CcSEcCtD
Ganciclovir—Chest pain—Pregabalin—epilepsy syndrome	6.24e-05	0.000143	CcSEcCtD
Ganciclovir—Ill-defined disorder—Gabapentin—epilepsy syndrome	6.24e-05	0.000143	CcSEcCtD
Ganciclovir—Dizziness—Zonisamide—epilepsy syndrome	6.24e-05	0.000143	CcSEcCtD
Ganciclovir—Headache—Diazepam—epilepsy syndrome	6.24e-05	0.000143	CcSEcCtD
Ganciclovir—Anxiety—Pregabalin—epilepsy syndrome	6.22e-05	0.000142	CcSEcCtD
Ganciclovir—Diarrhoea—Clonazepam—epilepsy syndrome	6.22e-05	0.000142	CcSEcCtD
Ganciclovir—Anaemia—Gabapentin—epilepsy syndrome	6.21e-05	0.000142	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	6.2e-05	0.000142	CcSEcCtD
Ganciclovir—Hypotension—Valproic Acid—epilepsy syndrome	6.18e-05	0.000141	CcSEcCtD
Ganciclovir—Asthenia—Carbamazepine—epilepsy syndrome	6.18e-05	0.000141	CcSEcCtD
Ganciclovir—Agitation—Gabapentin—epilepsy syndrome	6.18e-05	0.000141	CcSEcCtD
Ganciclovir—Diarrhoea—Phenytoin—epilepsy syndrome	6.18e-05	0.000141	CcSEcCtD
Ganciclovir—Discomfort—Pregabalin—epilepsy syndrome	6.17e-05	0.000141	CcSEcCtD
Ganciclovir—Nausea—Fosphenytoin—epilepsy syndrome	6.16e-05	0.000141	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.15e-05	0.000787	CbGpPWpGaD
Ganciclovir—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.14e-05	0.000141	CcSEcCtD
Ganciclovir—Erythema multiforme—Topiramate—epilepsy syndrome	6.14e-05	0.000141	CcSEcCtD
Ganciclovir—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.14e-05	0.00014	CcSEcCtD
Ganciclovir—Vomiting—Felbamate—epilepsy syndrome	6.13e-05	0.00014	CcSEcCtD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	6.11e-05	0.000782	CbGpPWpGaD
Ganciclovir—Dry mouth—Pregabalin—epilepsy syndrome	6.1e-05	0.00014	CcSEcCtD
Ganciclovir—Pruritus—Carbamazepine—epilepsy syndrome	6.1e-05	0.000139	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.1e-05	0.00078	CbGpPWpGaD
Ganciclovir—Rash—Felbamate—epilepsy syndrome	6.07e-05	0.000139	CcSEcCtD
Ganciclovir—Dermatitis—Felbamate—epilepsy syndrome	6.07e-05	0.000139	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—CA4—epilepsy syndrome	6.07e-05	0.000777	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—QDPR—epilepsy syndrome	6.07e-05	0.000777	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	6.06e-05	0.000776	CbGpPWpGaD
Ganciclovir—Malaise—Gabapentin—epilepsy syndrome	6.06e-05	0.000139	CcSEcCtD
Ganciclovir—Tinnitus—Topiramate—epilepsy syndrome	6.06e-05	0.000139	CcSEcCtD
Ganciclovir—Vertigo—Gabapentin—epilepsy syndrome	6.04e-05	0.000138	CcSEcCtD
Ganciclovir—Headache—Felbamate—epilepsy syndrome	6.04e-05	0.000138	CcSEcCtD
Ganciclovir—Confusional state—Pregabalin—epilepsy syndrome	6.03e-05	0.000138	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	6.03e-05	0.000138	CcSEcCtD
Ganciclovir—Leukopenia—Gabapentin—epilepsy syndrome	6.02e-05	0.000138	CcSEcCtD
Ganciclovir—Dizziness—Clonazepam—epilepsy syndrome	6.01e-05	0.000138	CcSEcCtD
Ganciclovir—Nausea—Vigabatrin—epilepsy syndrome	6.01e-05	0.000137	CcSEcCtD
Ganciclovir—Vomiting—Zonisamide—epilepsy syndrome	6e-05	0.000137	CcSEcCtD
Ganciclovir—Insomnia—Valproic Acid—epilepsy syndrome	5.99e-05	0.000137	CcSEcCtD
Ganciclovir—Anaphylactic shock—Pregabalin—epilepsy syndrome	5.98e-05	0.000137	CcSEcCtD
Ganciclovir—Oedema—Pregabalin—epilepsy syndrome	5.98e-05	0.000137	CcSEcCtD
Ganciclovir—Asthenia—Lamotrigine—epilepsy syndrome	5.98e-05	0.000137	CcSEcCtD
Ganciclovir—Dizziness—Phenytoin—epilepsy syndrome	5.97e-05	0.000137	CcSEcCtD
Ganciclovir—Rash—Zonisamide—epilepsy syndrome	5.95e-05	0.000136	CcSEcCtD
Ganciclovir—Infection—Pregabalin—epilepsy syndrome	5.94e-05	0.000136	CcSEcCtD
Ganciclovir—Paraesthesia—Valproic Acid—epilepsy syndrome	5.94e-05	0.000136	CcSEcCtD
Ganciclovir—Dermatitis—Zonisamide—epilepsy syndrome	5.94e-05	0.000136	CcSEcCtD
Ganciclovir—Dizziness—Oxcarbazepine—epilepsy syndrome	5.94e-05	0.000136	CcSEcCtD
Ganciclovir—Nausea—Diazepam—epilepsy syndrome	5.91e-05	0.000135	CcSEcCtD
Ganciclovir—Headache—Zonisamide—epilepsy syndrome	5.91e-05	0.000135	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	5.9e-05	0.000756	CbGpPWpGaD
Ganciclovir—Dyspnoea—Valproic Acid—epilepsy syndrome	5.9e-05	0.000135	CcSEcCtD
Ganciclovir—Diarrhoea—Carbamazepine—epilepsy syndrome	5.9e-05	0.000135	CcSEcCtD
Ganciclovir—Angiopathy—Topiramate—epilepsy syndrome	5.89e-05	0.000135	CcSEcCtD
Ganciclovir—Pruritus—Lamotrigine—epilepsy syndrome	5.89e-05	0.000135	CcSEcCtD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	5.88e-05	0.000753	CbGpPWpGaD
Ganciclovir—Somnolence—Valproic Acid—epilepsy syndrome	5.88e-05	0.000135	CcSEcCtD
Ganciclovir—Cough—Gabapentin—epilepsy syndrome	5.87e-05	0.000134	CcSEcCtD
Ganciclovir—Thrombocytopenia—Pregabalin—epilepsy syndrome	5.86e-05	0.000134	CcSEcCtD
Ganciclovir—Mediastinal disorder—Topiramate—epilepsy syndrome	5.86e-05	0.000134	CcSEcCtD
Ganciclovir—Tachycardia—Pregabalin—epilepsy syndrome	5.84e-05	0.000134	CcSEcCtD
Ganciclovir—Chills—Topiramate—epilepsy syndrome	5.83e-05	0.000133	CcSEcCtD
Ganciclovir—Dyspepsia—Valproic Acid—epilepsy syndrome	5.83e-05	0.000133	CcSEcCtD
Ganciclovir—Convulsion—Gabapentin—epilepsy syndrome	5.82e-05	0.000133	CcSEcCtD
Ganciclovir—Skin disorder—Pregabalin—epilepsy syndrome	5.81e-05	0.000133	CcSEcCtD
Ganciclovir—Hypertension—Gabapentin—epilepsy syndrome	5.8e-05	0.000133	CcSEcCtD
Ganciclovir—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.78e-05	0.000132	CcSEcCtD
Ganciclovir—Vomiting—Clonazepam—epilepsy syndrome	5.78e-05	0.000132	CcSEcCtD
Ganciclovir—Decreased appetite—Valproic Acid—epilepsy syndrome	5.75e-05	0.000132	CcSEcCtD
Ganciclovir—Alopecia—Topiramate—epilepsy syndrome	5.74e-05	0.000131	CcSEcCtD
Ganciclovir—Vomiting—Phenytoin—epilepsy syndrome	5.74e-05	0.000131	CcSEcCtD
Ganciclovir—Rash—Clonazepam—epilepsy syndrome	5.73e-05	0.000131	CcSEcCtD
Ganciclovir—Dermatitis—Clonazepam—epilepsy syndrome	5.73e-05	0.000131	CcSEcCtD
Ganciclovir—Chest pain—Gabapentin—epilepsy syndrome	5.72e-05	0.000131	CcSEcCtD
Ganciclovir—Arthralgia—Gabapentin—epilepsy syndrome	5.72e-05	0.000131	CcSEcCtD
Ganciclovir—Myalgia—Gabapentin—epilepsy syndrome	5.72e-05	0.000131	CcSEcCtD
Ganciclovir—Nausea—Felbamate—epilepsy syndrome	5.72e-05	0.000131	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.71e-05	0.000131	CcSEcCtD
Ganciclovir—Vomiting—Oxcarbazepine—epilepsy syndrome	5.71e-05	0.000131	CcSEcCtD
Ganciclovir—Fatigue—Valproic Acid—epilepsy syndrome	5.71e-05	0.000131	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—COX3—epilepsy syndrome	5.7e-05	0.00073	CbGpPWpGaD
Ganciclovir—Anxiety—Gabapentin—epilepsy syndrome	5.7e-05	0.00013	CcSEcCtD
Ganciclovir—Anorexia—Pregabalin—epilepsy syndrome	5.7e-05	0.00013	CcSEcCtD
Ganciclovir—Dizziness—Carbamazepine—epilepsy syndrome	5.7e-05	0.00013	CcSEcCtD
Ganciclovir—Diarrhoea—Lamotrigine—epilepsy syndrome	5.7e-05	0.00013	CcSEcCtD
Ganciclovir—Headache—Clonazepam—epilepsy syndrome	5.69e-05	0.00013	CcSEcCtD
Ganciclovir—Rash—Phenytoin—epilepsy syndrome	5.69e-05	0.00013	CcSEcCtD
Ganciclovir—Mental disorder—Topiramate—epilepsy syndrome	5.69e-05	0.00013	CcSEcCtD
Ganciclovir—Dermatitis—Phenytoin—epilepsy syndrome	5.69e-05	0.00013	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.68e-05	0.00013	CcSEcCtD
Ganciclovir—Rash—Oxcarbazepine—epilepsy syndrome	5.66e-05	0.00013	CcSEcCtD
Ganciclovir—Pain—Valproic Acid—epilepsy syndrome	5.66e-05	0.000129	CcSEcCtD
Ganciclovir—Constipation—Valproic Acid—epilepsy syndrome	5.66e-05	0.000129	CcSEcCtD
Ganciclovir—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.66e-05	0.000129	CcSEcCtD
Ganciclovir—Headache—Phenytoin—epilepsy syndrome	5.66e-05	0.000129	CcSEcCtD
Ganciclovir—Malnutrition—Topiramate—epilepsy syndrome	5.66e-05	0.000129	CcSEcCtD
Ganciclovir—Discomfort—Gabapentin—epilepsy syndrome	5.65e-05	0.000129	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	5.64e-05	0.000722	CbGpPWpGaD
Ganciclovir—Headache—Oxcarbazepine—epilepsy syndrome	5.63e-05	0.000129	CcSEcCtD
Ganciclovir—Nausea—Zonisamide—epilepsy syndrome	5.6e-05	0.000128	CcSEcCtD
Ganciclovir—Dry mouth—Gabapentin—epilepsy syndrome	5.6e-05	0.000128	CcSEcCtD
Ganciclovir—Hypotension—Pregabalin—epilepsy syndrome	5.59e-05	0.000128	CcSEcCtD
Ganciclovir—Flatulence—Topiramate—epilepsy syndrome	5.57e-05	0.000128	CcSEcCtD
Ganciclovir—Tension—Topiramate—epilepsy syndrome	5.55e-05	0.000127	CcSEcCtD
Ganciclovir—Dysgeusia—Topiramate—epilepsy syndrome	5.54e-05	0.000127	CcSEcCtD
Ganciclovir—Confusional state—Gabapentin—epilepsy syndrome	5.53e-05	0.000127	CcSEcCtD
Ganciclovir—Dizziness—Lamotrigine—epilepsy syndrome	5.51e-05	0.000126	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	5.5e-05	0.000704	CbGpPWpGaD
Ganciclovir—Nervousness—Topiramate—epilepsy syndrome	5.49e-05	0.000126	CcSEcCtD
Ganciclovir—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.49e-05	0.000126	CcSEcCtD
Ganciclovir—Oedema—Gabapentin—epilepsy syndrome	5.49e-05	0.000126	CcSEcCtD
Ganciclovir—Vomiting—Carbamazepine—epilepsy syndrome	5.48e-05	0.000125	CcSEcCtD
Ganciclovir—Back pain—Topiramate—epilepsy syndrome	5.47e-05	0.000125	CcSEcCtD
Ganciclovir—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.45e-05	0.000125	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.45e-05	0.000125	CcSEcCtD
Ganciclovir—Infection—Gabapentin—epilepsy syndrome	5.45e-05	0.000125	CcSEcCtD
Ganciclovir—Muscle spasms—Topiramate—epilepsy syndrome	5.44e-05	0.000124	CcSEcCtD
Ganciclovir—Rash—Carbamazepine—epilepsy syndrome	5.43e-05	0.000124	CcSEcCtD
Ganciclovir—Dermatitis—Carbamazepine—epilepsy syndrome	5.43e-05	0.000124	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.41e-05	0.000124	CcSEcCtD
Ganciclovir—Insomnia—Pregabalin—epilepsy syndrome	5.41e-05	0.000124	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—KCNB1—epilepsy syndrome	5.41e-05	0.000692	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SLC6A8—epilepsy syndrome	5.41e-05	0.000692	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SLCO1A2—epilepsy syndrome	5.41e-05	0.000692	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CACNA2D2—epilepsy syndrome	5.41e-05	0.000692	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PFKL—epilepsy syndrome	5.41e-05	0.000692	CbGpPWpGaD
Ganciclovir—Nausea—Clonazepam—epilepsy syndrome	5.4e-05	0.000124	CcSEcCtD
Ganciclovir—Headache—Carbamazepine—epilepsy syndrome	5.4e-05	0.000124	CcSEcCtD
Ganciclovir—Paraesthesia—Pregabalin—epilepsy syndrome	5.37e-05	0.000123	CcSEcCtD
Ganciclovir—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.37e-05	0.000123	CcSEcCtD
Ganciclovir—Nausea—Phenytoin—epilepsy syndrome	5.36e-05	0.000123	CcSEcCtD
Ganciclovir—Tachycardia—Gabapentin—epilepsy syndrome	5.35e-05	0.000123	CcSEcCtD
Ganciclovir—Dyspnoea—Pregabalin—epilepsy syndrome	5.33e-05	0.000122	CcSEcCtD
Ganciclovir—Nausea—Oxcarbazepine—epilepsy syndrome	5.33e-05	0.000122	CcSEcCtD
Ganciclovir—Vision blurred—Topiramate—epilepsy syndrome	5.33e-05	0.000122	CcSEcCtD
Ganciclovir—Skin disorder—Gabapentin—epilepsy syndrome	5.33e-05	0.000122	CcSEcCtD
Ganciclovir—Somnolence—Pregabalin—epilepsy syndrome	5.32e-05	0.000122	CcSEcCtD
Ganciclovir—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.3e-05	0.000121	CcSEcCtD
Ganciclovir—Tremor—Topiramate—epilepsy syndrome	5.3e-05	0.000121	CcSEcCtD
Ganciclovir—Vomiting—Lamotrigine—epilepsy syndrome	5.3e-05	0.000121	CcSEcCtD
Ganciclovir—Urticaria—Valproic Acid—epilepsy syndrome	5.26e-05	0.00012	CcSEcCtD
Ganciclovir—Rash—Lamotrigine—epilepsy syndrome	5.25e-05	0.00012	CcSEcCtD
Ganciclovir—Ill-defined disorder—Topiramate—epilepsy syndrome	5.25e-05	0.00012	CcSEcCtD
Ganciclovir—Dermatitis—Lamotrigine—epilepsy syndrome	5.25e-05	0.00012	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	5.25e-05	0.000672	CbGpPWpGaD
Ganciclovir—Abdominal pain—Valproic Acid—epilepsy syndrome	5.23e-05	0.00012	CcSEcCtD
Ganciclovir—Body temperature increased—Valproic Acid—epilepsy syndrome	5.23e-05	0.00012	CcSEcCtD
Ganciclovir—Anorexia—Gabapentin—epilepsy syndrome	5.23e-05	0.00012	CcSEcCtD
Ganciclovir—Anaemia—Topiramate—epilepsy syndrome	5.23e-05	0.00012	CcSEcCtD
Ganciclovir—Headache—Lamotrigine—epilepsy syndrome	5.22e-05	0.000119	CcSEcCtD
Ganciclovir—Decreased appetite—Pregabalin—epilepsy syndrome	5.2e-05	0.000119	CcSEcCtD
Ganciclovir—Agitation—Topiramate—epilepsy syndrome	5.2e-05	0.000119	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.17e-05	0.000662	CbGpPWpGaD
Ganciclovir—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.17e-05	0.000118	CcSEcCtD
Ganciclovir—Fatigue—Pregabalin—epilepsy syndrome	5.16e-05	0.000118	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	5.16e-05	0.00066	CbGpPWpGaD
Ganciclovir—Hypotension—Gabapentin—epilepsy syndrome	5.13e-05	0.000117	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.12e-05	0.000656	CbGpPWpGaD
Ganciclovir—Nausea—Carbamazepine—epilepsy syndrome	5.12e-05	0.000117	CcSEcCtD
Ganciclovir—Pain—Pregabalin—epilepsy syndrome	5.12e-05	0.000117	CcSEcCtD
Ganciclovir—Constipation—Pregabalin—epilepsy syndrome	5.12e-05	0.000117	CcSEcCtD
Ganciclovir—Malaise—Topiramate—epilepsy syndrome	5.1e-05	0.000117	CcSEcCtD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	5.1e-05	0.000653	CbGpPWpGaD
Ganciclovir—Vertigo—Topiramate—epilepsy syndrome	5.08e-05	0.000116	CcSEcCtD
Ganciclovir—Leukopenia—Topiramate—epilepsy syndrome	5.06e-05	0.000116	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	5.03e-05	0.000643	CbGpPWpGaD
Ganciclovir—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5e-05	0.000114	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	4.96e-05	0.000635	CbGpPWpGaD
Ganciclovir—Insomnia—Gabapentin—epilepsy syndrome	4.96e-05	0.000114	CcSEcCtD
Ganciclovir—Nausea—Lamotrigine—epilepsy syndrome	4.95e-05	0.000113	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—ATIC—epilepsy syndrome	4.95e-05	0.000633	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—UPB1—epilepsy syndrome	4.95e-05	0.000633	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NEU1—epilepsy syndrome	4.95e-05	0.000633	CbGpPWpGaD
Ganciclovir—Cough—Topiramate—epilepsy syndrome	4.94e-05	0.000113	CcSEcCtD
Ganciclovir—Feeling abnormal—Pregabalin—epilepsy syndrome	4.93e-05	0.000113	CcSEcCtD
Ganciclovir—Paraesthesia—Gabapentin—epilepsy syndrome	4.93e-05	0.000113	CcSEcCtD
Ganciclovir—Convulsion—Topiramate—epilepsy syndrome	4.9e-05	0.000112	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.89e-05	0.000112	CcSEcCtD
Ganciclovir—Dyspnoea—Gabapentin—epilepsy syndrome	4.89e-05	0.000112	CcSEcCtD
Ganciclovir—Hypertension—Topiramate—epilepsy syndrome	4.88e-05	0.000112	CcSEcCtD
Ganciclovir—Somnolence—Gabapentin—epilepsy syndrome	4.88e-05	0.000112	CcSEcCtD
Ganciclovir—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.88e-05	0.000112	CcSEcCtD
Ganciclovir—Dyspepsia—Gabapentin—epilepsy syndrome	4.83e-05	0.00011	CcSEcCtD
Ganciclovir—Myalgia—Topiramate—epilepsy syndrome	4.81e-05	0.00011	CcSEcCtD
Ganciclovir—Chest pain—Topiramate—epilepsy syndrome	4.81e-05	0.00011	CcSEcCtD
Ganciclovir—Arthralgia—Topiramate—epilepsy syndrome	4.81e-05	0.00011	CcSEcCtD
Ganciclovir—Anxiety—Topiramate—epilepsy syndrome	4.8e-05	0.00011	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.78e-05	0.000109	CcSEcCtD
Ganciclovir—Decreased appetite—Gabapentin—epilepsy syndrome	4.77e-05	0.000109	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—HSD17B4—epilepsy syndrome	4.76e-05	0.000609	CbGpPWpGaD
Ganciclovir—Discomfort—Topiramate—epilepsy syndrome	4.76e-05	0.000109	CcSEcCtD
Ganciclovir—Urticaria—Pregabalin—epilepsy syndrome	4.75e-05	0.000109	CcSEcCtD
Ganciclovir—Asthenia—Valproic Acid—epilepsy syndrome	4.75e-05	0.000109	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.74e-05	0.000108	CcSEcCtD
Ganciclovir—Fatigue—Gabapentin—epilepsy syndrome	4.73e-05	0.000108	CcSEcCtD
Ganciclovir—Abdominal pain—Pregabalin—epilepsy syndrome	4.73e-05	0.000108	CcSEcCtD
Ganciclovir—Body temperature increased—Pregabalin—epilepsy syndrome	4.73e-05	0.000108	CcSEcCtD
Ganciclovir—Dry mouth—Topiramate—epilepsy syndrome	4.71e-05	0.000108	CcSEcCtD
Ganciclovir—Pain—Gabapentin—epilepsy syndrome	4.69e-05	0.000107	CcSEcCtD
Ganciclovir—Constipation—Gabapentin—epilepsy syndrome	4.69e-05	0.000107	CcSEcCtD
Ganciclovir—Pruritus—Valproic Acid—epilepsy syndrome	4.68e-05	0.000107	CcSEcCtD
Ganciclovir—Confusional state—Topiramate—epilepsy syndrome	4.65e-05	0.000106	CcSEcCtD
Ganciclovir—Oedema—Topiramate—epilepsy syndrome	4.62e-05	0.000106	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—PPP1R3C—epilepsy syndrome	4.6e-05	0.000589	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GBE1—epilepsy syndrome	4.6e-05	0.000589	CbGpPWpGaD
Ganciclovir—Infection—Topiramate—epilepsy syndrome	4.59e-05	0.000105	CcSEcCtD
Ganciclovir—Diarrhoea—Valproic Acid—epilepsy syndrome	4.53e-05	0.000104	CcSEcCtD
Ganciclovir—Feeling abnormal—Gabapentin—epilepsy syndrome	4.52e-05	0.000103	CcSEcCtD
Ganciclovir—Thrombocytopenia—Topiramate—epilepsy syndrome	4.52e-05	0.000103	CcSEcCtD
Ganciclovir—SLC22A1—Neuronal System—PRKCB—epilepsy syndrome	4.51e-05	0.000577	CbGpPWpGaD
Ganciclovir—Tachycardia—Topiramate—epilepsy syndrome	4.5e-05	0.000103	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.49e-05	0.000103	CcSEcCtD
Ganciclovir—Skin disorder—Topiramate—epilepsy syndrome	4.48e-05	0.000103	CcSEcCtD
Ganciclovir—Hyperhidrosis—Topiramate—epilepsy syndrome	4.46e-05	0.000102	CcSEcCtD
Ganciclovir—Hypersensitivity—Pregabalin—epilepsy syndrome	4.41e-05	0.000101	CcSEcCtD
Ganciclovir—Anorexia—Topiramate—epilepsy syndrome	4.4e-05	0.000101	CcSEcCtD
Ganciclovir—Dizziness—Valproic Acid—epilepsy syndrome	4.38e-05	0.0001	CcSEcCtD
Ganciclovir—Urticaria—Gabapentin—epilepsy syndrome	4.36e-05	9.97e-05	CcSEcCtD
Ganciclovir—Body temperature increased—Gabapentin—epilepsy syndrome	4.34e-05	9.92e-05	CcSEcCtD
Ganciclovir—Abdominal pain—Gabapentin—epilepsy syndrome	4.34e-05	9.92e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—ASAH1—epilepsy syndrome	4.32e-05	0.000553	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.32e-05	0.000552	CbGpPWpGaD
Ganciclovir—Hypotension—Topiramate—epilepsy syndrome	4.31e-05	9.87e-05	CcSEcCtD
Ganciclovir—Asthenia—Pregabalin—epilepsy syndrome	4.29e-05	9.82e-05	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.28e-05	0.000547	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	4.27e-05	0.000547	CbGpPWpGaD
Ganciclovir—Pruritus—Pregabalin—epilepsy syndrome	4.23e-05	9.68e-05	CcSEcCtD
Ganciclovir—Vomiting—Valproic Acid—epilepsy syndrome	4.21e-05	9.63e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—STXBP1—epilepsy syndrome	4.21e-05	0.000538	CbGpPWpGaD
Ganciclovir—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.21e-05	9.62e-05	CcSEcCtD
Ganciclovir—Insomnia—Topiramate—epilepsy syndrome	4.17e-05	9.55e-05	CcSEcCtD
Ganciclovir—Rash—Valproic Acid—epilepsy syndrome	4.17e-05	9.55e-05	CcSEcCtD
Ganciclovir—Dermatitis—Valproic Acid—epilepsy syndrome	4.17e-05	9.54e-05	CcSEcCtD
Ganciclovir—Headache—Valproic Acid—epilepsy syndrome	4.15e-05	9.49e-05	CcSEcCtD
Ganciclovir—Paraesthesia—Topiramate—epilepsy syndrome	4.14e-05	9.48e-05	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	4.14e-05	0.00053	CbGpPWpGaD
Ganciclovir—Dyspnoea—Topiramate—epilepsy syndrome	4.12e-05	9.42e-05	CcSEcCtD
Ganciclovir—Somnolence—Topiramate—epilepsy syndrome	4.1e-05	9.39e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—NT5E—epilepsy syndrome	4.1e-05	0.000525	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ALAD—epilepsy syndrome	4.1e-05	0.000525	CbGpPWpGaD
Ganciclovir—Diarrhoea—Pregabalin—epilepsy syndrome	4.09e-05	9.37e-05	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	4.08e-05	0.000522	CbGpPWpGaD
Ganciclovir—Dyspepsia—Topiramate—epilepsy syndrome	4.06e-05	9.3e-05	CcSEcCtD
Ganciclovir—Hypersensitivity—Gabapentin—epilepsy syndrome	4.04e-05	9.25e-05	CcSEcCtD
Ganciclovir—Decreased appetite—Topiramate—epilepsy syndrome	4.01e-05	9.18e-05	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.98e-05	9.12e-05	CcSEcCtD
Ganciclovir—Fatigue—Topiramate—epilepsy syndrome	3.98e-05	9.1e-05	CcSEcCtD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	3.96e-05	0.000507	CbGpPWpGaD
Ganciclovir—Dizziness—Pregabalin—epilepsy syndrome	3.96e-05	9.05e-05	CcSEcCtD
Ganciclovir—Pain—Topiramate—epilepsy syndrome	3.95e-05	9.03e-05	CcSEcCtD
Ganciclovir—Constipation—Topiramate—epilepsy syndrome	3.95e-05	9.03e-05	CcSEcCtD
Ganciclovir—Asthenia—Gabapentin—epilepsy syndrome	3.94e-05	9.01e-05	CcSEcCtD
Ganciclovir—Nausea—Valproic Acid—epilepsy syndrome	3.93e-05	8.99e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—CACNA1A—epilepsy syndrome	3.91e-05	0.0005	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ALDH7A1—epilepsy syndrome	3.91e-05	0.0005	CbGpPWpGaD
Ganciclovir—Pruritus—Gabapentin—epilepsy syndrome	3.88e-05	8.88e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—ST3GAL3—epilepsy syndrome	3.83e-05	0.00049	CbGpPWpGaD
Ganciclovir—Vomiting—Pregabalin—epilepsy syndrome	3.8e-05	8.7e-05	CcSEcCtD
Ganciclovir—Feeling abnormal—Topiramate—epilepsy syndrome	3.8e-05	8.7e-05	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.77e-05	8.64e-05	CcSEcCtD
Ganciclovir—Rash—Pregabalin—epilepsy syndrome	3.77e-05	8.63e-05	CcSEcCtD
Ganciclovir—Dermatitis—Pregabalin—epilepsy syndrome	3.77e-05	8.62e-05	CcSEcCtD
Ganciclovir—Diarrhoea—Gabapentin—epilepsy syndrome	3.75e-05	8.59e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—ADSL—epilepsy syndrome	3.75e-05	0.00048	CbGpPWpGaD
Ganciclovir—Headache—Pregabalin—epilepsy syndrome	3.75e-05	8.58e-05	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.69e-05	0.000473	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GLUL—epilepsy syndrome	3.68e-05	0.000471	CbGpPWpGaD
Ganciclovir—Urticaria—Topiramate—epilepsy syndrome	3.67e-05	8.39e-05	CcSEcCtD
Ganciclovir—Abdominal pain—Topiramate—epilepsy syndrome	3.65e-05	8.35e-05	CcSEcCtD
Ganciclovir—Body temperature increased—Topiramate—epilepsy syndrome	3.65e-05	8.35e-05	CcSEcCtD
Ganciclovir—Dizziness—Gabapentin—epilepsy syndrome	3.63e-05	8.3e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—CACNA1D—epilepsy syndrome	3.61e-05	0.000462	CbGpPWpGaD
Ganciclovir—Nausea—Pregabalin—epilepsy syndrome	3.55e-05	8.13e-05	CcSEcCtD
Ganciclovir—Vomiting—Gabapentin—epilepsy syndrome	3.49e-05	7.98e-05	CcSEcCtD
Ganciclovir—Rash—Gabapentin—epilepsy syndrome	3.46e-05	7.91e-05	CcSEcCtD
Ganciclovir—Dermatitis—Gabapentin—epilepsy syndrome	3.46e-05	7.91e-05	CcSEcCtD
Ganciclovir—Headache—Gabapentin—epilepsy syndrome	3.44e-05	7.86e-05	CcSEcCtD
Ganciclovir—Hypersensitivity—Topiramate—epilepsy syndrome	3.4e-05	7.78e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—TXNRD1—epilepsy syndrome	3.37e-05	0.000432	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.35e-05	0.000429	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.32e-05	0.000425	CbGpPWpGaD
Ganciclovir—Asthenia—Topiramate—epilepsy syndrome	3.31e-05	7.58e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—AQP1—epilepsy syndrome	3.28e-05	0.000419	CbGpPWpGaD
Ganciclovir—Pruritus—Topiramate—epilepsy syndrome	3.27e-05	7.47e-05	CcSEcCtD
Ganciclovir—Nausea—Gabapentin—epilepsy syndrome	3.26e-05	7.46e-05	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.22e-05	0.000412	CbGpPWpGaD
Ganciclovir—Diarrhoea—Topiramate—epilepsy syndrome	3.16e-05	7.23e-05	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.1e-05	0.000397	CbGpPWpGaD
Ganciclovir—Dizziness—Topiramate—epilepsy syndrome	3.05e-05	6.98e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—KCNJ11—epilepsy syndrome	2.96e-05	0.000379	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CHRM3—epilepsy syndrome	2.96e-05	0.000379	CbGpPWpGaD
Ganciclovir—Vomiting—Topiramate—epilepsy syndrome	2.93e-05	6.71e-05	CcSEcCtD
Ganciclovir—Rash—Topiramate—epilepsy syndrome	2.91e-05	6.66e-05	CcSEcCtD
Ganciclovir—Dermatitis—Topiramate—epilepsy syndrome	2.91e-05	6.65e-05	CcSEcCtD
Ganciclovir—Headache—Topiramate—epilepsy syndrome	2.89e-05	6.62e-05	CcSEcCtD
Ganciclovir—Nausea—Topiramate—epilepsy syndrome	2.74e-05	6.27e-05	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.59e-05	0.000332	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ABCG2—epilepsy syndrome	2.42e-05	0.000309	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP2C19—epilepsy syndrome	2.35e-05	0.000301	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP11A1—epilepsy syndrome	2.34e-05	0.000299	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP2D6—epilepsy syndrome	2.11e-05	0.00027	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.01e-05	0.000258	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ADRA2A—epilepsy syndrome	2.01e-05	0.000257	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—BCHE—epilepsy syndrome	2e-05	0.000256	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SLC2A1—epilepsy syndrome	1.91e-05	0.000244	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PLCB1—epilepsy syndrome	1.89e-05	0.000242	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—TH—epilepsy syndrome	1.88e-05	0.000241	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HMOX1—epilepsy syndrome	1.57e-05	0.000201	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CAT—epilepsy syndrome	1.55e-05	0.000198	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ABCB1—epilepsy syndrome	1.51e-05	0.000193	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GPX1—epilepsy syndrome	1.4e-05	0.000179	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—AGT—epilepsy syndrome	1.23e-05	0.000157	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—APOE—epilepsy syndrome	1.2e-05	0.000154	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—POMC—epilepsy syndrome	1.03e-05	0.000132	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ALB—epilepsy syndrome	9.43e-06	0.000121	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	8.25e-06	0.000106	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—AKT1—epilepsy syndrome	4.15e-06	5.31e-05	CbGpPWpGaD
